SIGLEC1 and neoplasm: In summary, our data suggest that an increased in the frequency of CD14+CD169+ cells may be associated with the development and progression of CRC and is concomitant rise of both pro-tumor (M2-like, IL-10 producing) and anti-tumor (M1-like, IL-12 producing) monocytes and infiltrating macrophages.